COVID-19: TN govt gives consent to BCG trial at ICMR’s Chennai institute
The National Institute for Research in Tuberculosis under the ICMR is an internationally recognised institution for TB research
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Advertisement
Chennai, July 15
Sanction has been accorded to a trial by the Indian Council of Medical Research’s Tuberculosis institute here to study the efficacy of BCG vaccine in the elderly in the fight against COVID-19, the government said on Wednesday.
Advertisement
Chief Minister K Palaniswami, in an order, has given the state’s approval after the ICMR sought Tamil Nadu government’s permission to study the efficacy of the Bacillus Calmette- Gurin (BCG) vaccine in senior citizens at its National Institute for Research in Tuberculosis (NIRT) at Chetpet here,Health Minister C Vijayabaskar said.
“The ICMR’s tuberculosis institute is set to begin the trial very soon,” he said in a statement.
He hoped that vaccinating the elderly with the time-tested BCG would help reduce the intensity of COVID-19, admissions at hospitals and mortality rates.
Advertisement
Describing the state’s approval by Palaniswami for a trial here as among measures to protect people’s welfare during the ongoing fight against COVID-19, Vijayabaskar said anti-viral measures would further be stepped up.
The NIRT under the ICMR is an internationally recognised institution for TB research. PTI
Advertisement
Advertisement